Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel NvfiledCriticalAkzo Nobel Nv
Publication of PE20030442A1publicationCriticalpatent/PE20030442A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
SE REFIERE A 17ALFA-HIDROXI-14BETA-ESTEROIDES CON EFECTOS HORMONALES DE FORMULA I DONDE R1 ES O, (H,H), (H,OH), NOH DONDE OH ESTA OPCIONALMENTE ESTERIFICADO O ESTERIFICADO; R2 Y R3 SON H, ALQUILO C1-C4 Y AL MENOS UNO DE ELLOS ES ALQUILO C1-C4; R4 ES H O ACILO C1-C15. EL COMPUESTO DE (7O,14ß,16ß,17O)-17-HIDROXI-7,16-DIMETILESTR-4-EN-3-ONA. EL COMPUESTO ES USADO PARA EL TRATAMIENTO DE ANTICONCEPCION MASCULINA O TERAPIA DE REEMPLAZO HORMONAL MASCULINA O FEMENINA.REFERS TO 17ALPHA-HYDROXY-14BETA-STEROIDS WITH HORMONAL EFFECTS OF FORMULA I WHERE R1 IS O, (H, H), (H, OH), NOH WHERE OH IS OPTIONALLY STERIFIED OR STERIFIED; R2 AND R3 ARE H, C1-C4 ALKYL AND AT LEAST ONE OF THEM IS C1-C4 ALKYL; R4 IS H O ACILO C1-C15. THE COMPOUND OF (7O, 14ß, 16ß, 17O) -17-HYDROXY-7,16-DIMETHYLESTR-4-EN-3-ONA. THE COMPOUND IS USED FOR THE TREATMENT OF MALE CONTRACEPTION OR MALE OR FEMALE HORMONE REPLACEMENT THERAPY.
PE2002000892A2001-09-122002-09-10
17ALFA-HYDROXY-14BETA-STEROIDS WITH ANDROGENIC ACTIVITY AND METABOLIC STABILITY
PE20030442A1
(en)
HALOGENATED DERIVATIVE COMPOUND OF HEPTENOIC ACID 2-AMINO-4,5, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND THE USE OF SUCH COMPOUND AND SUCH COMPOSITION IN THE MANUFACTURE OF A MEDICINAL PRODUCT TO INHIBIT OR MODULATE NITRIC ACID SYNTHESIS